bioAffinity Technologies (BIAF) Earnings Date & Reports

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI)... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BIAF is expected to report earnings to rise 159.26% to -209 cents per share on August 19

bioAffinity Technologies BIAF Stock Earnings Reports

Q2'26

Est.

$-2.10

Q1'26

Missed

by $0.73

Q4'25

Missed

by $0.61

Q3'25

Missed

by $4.65

Q2'25

Missed

by $0.07

The last earnings report on May 08 showed earnings per share of -81 cents, missing the estimate of -8 cents. With 374.10K shares outstanding, the current market capitalization sits at 5.09M.

View a ticker or compare two or three

Compare

BIAF

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BIAF